Literature DB >> 14972419

Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography.

Raphael Rosenhek1, Ursula Klaar, Michael Schemper, Christine Scholten, Maria Heger, Harald Gabriel, Thomas Binder, Gerald Maurer, Helmut Baumgartner.   

Abstract

AIMS: To define the natural history and predictors of outcome in mild and moderate aortic stenosis (AS). METHODS AND
RESULTS: One hundred and seventy-six consecutive asymptomatic patients (73 women, age 58+/-19 years) with mild to moderate AS (jet velocity 2.5 to 3.9m/s) were followed for 48+/-19 months. Haemodynamic progression and clinical outcome was analysed. Event-free survival with end-points defined as death (n=34) or aortic valve surgery (n=33), was 95+/-2%, 75+/-3% and 60+/-5% at 1, 3 and 5 years, respectively. Both, cardiac and non-cardiac mortality were significantly increased, resulting in a 1.8 times higher mortality than expected (P<0.005). By multivariate analysis, moderate to severe aortic valve calcification, coronary artery disease (CAD) and peak jet velocity were independent predictors of outcome. Event-free survival for patients with moderate or severe valve calcification was 92+/-4%, 61+/-7% and 42+/-7% at 1, 3 and 5 years versus 100%, 90+/-4% and 82+/-5% for patients with no or mild calcification. Patients with calcified aortic valves, CAD or with an event had a significantly faster haemodynamic progression. Of 129 patients with a follow-up echocardiographic exam, 59 (46%) developed severe stenosis during follow-up.
CONCLUSION: Outcome of mild and moderate AS is worse than commonly assumed. Rapid progression and excess mortality have to be considered. Significant valve calcification, CAD and rapid progression of aortic jet velocity indicate poor outcome. Patients with these characteristics may require closer follow-up than generally assumed.

Entities:  

Mesh:

Year:  2004        PMID: 14972419     DOI: 10.1016/j.ehj.2003.12.002

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  87 in total

1.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

2.  Incremental prognostic role of left atrial reservoir strain in asymptomatic patients with moderate aortic stenosis.

Authors:  Andrea Sonaglioni; Gian Luigi Nicolosi; Elisabetta Rigamonti; Michele Lombardo
Journal:  Int J Cardiovasc Imaging       Date:  2021-02-05       Impact factor: 2.357

Review 3.  Surgical aspects of congestive heart failure.

Authors:  Daniel J Goldstein; Douglas Smego; Robert E Michler
Journal:  Heart Fail Rev       Date:  2006-06       Impact factor: 4.214

Review 4.  [Aortic stenosis].

Authors:  W G Daniel; H Baumgartner; C Gohlke-Bärwolf; P Hanrath; D Horstkotte; K C Koch; A Mügge; H J Schäfers; F A Flachskampf
Journal:  Clin Res Cardiol       Date:  2006-11       Impact factor: 5.460

Review 5.  Degenerative aortic stenosis.

Authors:  Radhakrishnan Ramaraj; Vincent L Sorrell
Journal:  BMJ       Date:  2008-03-08

Review 6.  When is concomitant aortic valve replacement indicated in patients with mild to moderate stenosis undergoing coronary revascularization?

Authors:  A Marc Gillinov; Mario J Garcia
Journal:  Curr Cardiol Rep       Date:  2005-03       Impact factor: 2.931

7.  The quest for the unholy grail.

Authors:  T Kimball
Journal:  Pediatr Cardiol       Date:  2008-05       Impact factor: 1.655

8.  Exercise stress echocardiography in patients with aortic stenosis: impact of baseline diastolic dysfunction and functional capacity on mortality and aortic valve replacement.

Authors:  Andrew N Rassi; Wael Aljaroudi; Sahar Naderi; M Chadi Alraies; Venu Menon; Leonardo Rodriguez; Richard Grimm; Brian Griffin; Wael A Jaber
Journal:  Cardiovasc Diagn Ther       Date:  2013-12

9.  Moderate or severe valvular heart disease and outcomes in allogeneic stem cell transplantation.

Authors:  Robin M Brusen; Richard K Cheng; Sophia C Masri; Douglas Leedy; Mohamed L Sorror
Journal:  Int J Cardiol       Date:  2019-05-25       Impact factor: 4.164

10.  Antioxidant enzymes reduce DNA damage and early activation of valvular interstitial cells in aortic valve sclerosis.

Authors:  Emanuela Branchetti; Rachana Sainger; Paolo Poggio; Juan B Grau; Jeffrey Patterson-Fortin; Joseph E Bavaria; Michael Chorny; Eric Lai; Robert C Gorman; Robert J Levy; Giovanni Ferrari
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.